About Benjamin Yerxa
Benjamin Yerxa is a president and director at Opus Genetics.
Benjamin Yerxa reports to the SEC as a director or officer of 3 public companies, including Clearside Biomedical (CLSD) and Inspire Pharmaceuticals (ISPH).
Benjamin Yerxa first appears on SEC filings in 2006.
Experience
This experience comes from SEC filings. The years are when the filings name Benjamin Yerxa in the role, so the role may have started earlier or lasted longer.
CI
Clearside Biomedical, Inc.
Director
2022 – 2024 · Public company (CLSD)
II
Inspire Pharmaceuticals Inc.
EVP & Chf, Research & Develop
2006 – 2010 · Public company (ISPH)
Key Colleagues at Startups
The people Benjamin Yerxa works with at each company, as listed on that company's latest Form D.
Opus Genetics Inc. · Form D, Jun 27, 2023